Waters Corp. and BD announced a definitive agreement July 14 to combine BD’s Biosciences & Diagnostic Solutions businesses with the Milford, Mass.-based company. The deal is structured as a ...
AUSTIN, Texas--(BUSINESS WIRE)--Babson Diagnostics, a science-first healthcare technology company, today announced that BD (Becton, Dickinson and Company), a leading global medical technology company, ...
As the market for GLP-1 injections continues to grow, BD aims to ride that wave by providing drugmakers with its prefilled syringes. Biologic medications—including those blockbusters for diabetes and ...
BROKEN BOW, Neb., Oct. 16, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, proudly commemorates 65 years of manufacturing excellence ...
Q4 revenue of $5.9 billion increased 8.3% as reported, 7.0% FXN and 3.9% organic Q4 GAAP and adjusted diluted EPS grew to $1.72 and $3.96, respectively FY25 revenue of $21.8 billion increased 8.2% as ...
Company inaugurates groundbreaking Training Center in Riyadh, empowering healthcare professionals with advanced education, fostering innovation, and supporting Saudi Arabia’s Vision 2030 healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback